Collaborative Interdisciplinary Research Program in Diabetes, Endocrinology and Metabolic Diseases (R24)

The summary for the Collaborative Interdisciplinary Research Program in Diabetes, Endocrinology and Metabolic Diseases (R24) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Collaborative Interdisciplinary Research Program in Diabetes, Endocrinology and Metabolic Diseases (R24): The complexity and pace of biomedical science often requires input and expertise from many more than one investigator. Currently support for collaborative research takes the form of a large R01 with one Principal Investigator (PI) and one or more key personnel,, a multi-PI R01, or a Program Project Grant (P01) with 3 or more individual and independent projects and cores centered on a common theme, or a Center supporting a focused set of activities. Other large research mechanisms often utilize cooperative agreements that also entail significant involvement of the NIH in the planning and execution of research objectives. In large collaborative studies synergies are built out of the interactions between and among the projects and investigators of these focused efforts. It is becoming clear that mechanism(s) to support collaborative (team) science in ways not amenable to the R01, P01, or Center are needed to address complex problems in biomedical sciences that require multiple and often different expertise. In 2003 the Bioengineering Consortium of the NIH held a workshop entitled Catalyzing Team Science that focused on the need to bring to bear multiple and differing expertise on problems that were of a complexity and scope that called for the need to apply a team approach to the problem.
Federal Grant Title: Collaborative Interdisciplinary Research Program in Diabetes, Endocrinology and Metabolic Diseases (R24)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-07-188
Type of Funding: Grant
CFDA Numbers: 93.847
CFDA Descriptions: Diabetes, Endocrinology and Metabolism Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Dec 19, 2006
Creation Date: Dec 19, 2006
Archive Date: Mar 24, 2008
Total Program Funding: $750,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education Small businesses For profit organizations other than small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility
Foreign institutions are not eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogen...
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors...
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Requ...
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements...
Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
Molecular Therapy Core Centers
Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com